BRISBANE, Calif. , Oct. 13, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech company focused on developing novel treatments for neurogenetic diseases, announced today that the U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to DTx-1252, an investigational small interfering RNA therapeutic to ...
Vanda Pharmaceuticals Inc.'s antisense oligonucleotide (ASO) VCA-894A has been awarded orphan drug designation by the FDA for the treatment of Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback